Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 ...
In Canada, colorectal cancer is projected to be the fourth most commonly diagnosed cancer in 2024 (excluding non-melanoma skin cancers), according to the Canadian Cancer Society.